This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Pierre-Emmanuel Broutin, PhD
Project Chemist at Polypeptide Group

Profile

Pierre-Emmanuel Broutin studied in Mulhouse (France) where he received a degree in chemical engineering and MSc in organic and bio-organic chemistry. He completed a Ph.D. in 2005 toward asymmetric Suzuki coupling with enantiopure sulfoxides as chiral inductors at Strasbourg in the group of Pr. Françoise COLOBERT. After one year at the Roskamp Institute (USA) working in lead optimization for the treatment of Alzheimer disease, he joined NovAliX (France) for 8 years where he was involved in several early phase medicinal chemistry projects. Pierre-Emmanuel joined Polypeptide (France) in 2016 as a project chemist for development of processes for GMP manufacture. Since February 2021, he is managing the transfer of projects between Strasbourg and other PPL sites with a focus in the transfer within the PPL Business Unit formed by PPL Braine (Belgium) and PPL Strasbourg (France).

Agenda Sessions

  • Technology Transfer of Multi Peptides - A Case Study

    08:45